NSEGeneral Updates26 Jun 2026 · 26 Jun 2026, 06:26 pm

General Updates

Medplus Health Services Limited · MEDPLUS

✦ AI Summary▼ NegativeRegulatory

MedPlus Health Services Limited has received three suspension orders for a Drug License of its subsidiary Optival Health Solutions Private Limited, resulting in a potential revenue loss of Rs 0.22 lacs, Rs 0.60 lacs, and Rs 0.76 lacs for one, two, and three days respectively.

Analysis Scores

Earnings Impact6/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

MEDPLUS_26062026182606_Intimation.pdf

pdf

Download →
View document text
MedPlus Health Services Limited June 26, 2026 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received three suspension orders for a Drug License of a store situated in the state of Karnataka and Andra Pradesh: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Authority Nature and details of the Date of receipt of Details of the Impact on financial action(s) taken, initiated direction or order, violation(s)/ operation or other or order(s) passed including any contravention(s) activities of the interim or interim committed or alleged listed entity, orders, or any other to be committed quantifiable in communication monetary terms to from the authority the extent possible Assistant Director,Drugs Suspension of Drug Potential Revenue Control Administration, Hubli License for one day of Loss of Rs 0.22 lacs. Circle, Hubli Karnataka. store situated at Adarsha Nagar Hubli , Karnataka. Assistant Director, Drugs Suspension of Drug Potential Revenue Order received on Under Rule 65 of Drugs Control Adminstration, Gadag License for two days of Loss of Rs 0.60 lacs. 25.06.2026 and Cosmetics Act, Circle, Gadag Karnataka. store situated at Rani 1940 and Drugs and Road Gadag, Karnataka. Cosmetics Rules, 1945 Assistant Director, Drugs Suspension of Drug Potential Revenue Control Administration, License for three days of Loss of Rs 0.76 lacs. Serilingampally Andra pradesh. store situated Radhakrishna Nagar Attapur Andra pradesh The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Gangadi Madhukar Reddy Managing Director and Chief Executive Officer DIN: 00098097 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com